We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current HBPCF market cap is 22.3M. The company's latest EPS is CAD -0.1890 and P/E is -5.19.
| Year End 31 July 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.62M | -9.13M | -5.87M | -6.22M | -9.01M |
| Net Income | -9.17M | -8.04M | -6.56M | -6.29M | -9.26M |
| Year End 31 July 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 4.91M | 4.07M | 3.73M | 1.03M | 1.49M |
| Total Liabilities | 1.93M | 5.46M | 3.41M | 1.87M | 1.58M |
| Total Equity | 2.98M | -1.39M | 319k | -844k | -90k |
| Year End 31 July 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -10.83M | -9.3M | -6.51M | -5.53M | -5.22M |
| Investing | 1.7M | 2.02M | N/A | -5k | -14k |
| Financing | 13.1M | 6.56M | 6.21M | 3.09M | 5.51M |
| Market Cap | 22.3M |
| Price to Earnings Ratio | -5.19 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 44.34 |
| Price to Book Ratio | -533.79 |
| Dividend Yield | - |
| Shares Outstanding | 49.02M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -35.61% |
| 52 Week High | 0.9169 |
| 52 Week Low | 0.4549 |
| Spread (Intraday) | 1.05 (99.99%) |
| Company Name | Helix BioPharma Company (PK) |
| Address |
2704, 401 bay street toronto, ontario M5H 2Y4 |
| Website | https://www.helixbiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
